Method of obtaining multileaflet
Disclosed is a method for obtaining multileaflet Medicago sativa materials by means of MsPALM1 artificial site-directed mutants. The method comprises: selecting a target site from an exon region of a compound leaf developmental regulatory gene MsPALM1 of Medicago sativa and constructing a plant CRISPR/Cas9 editing recombinant vector MsCRISPR/Cas9::PALM1 and introducing the vector into Medicago sativa cells and regenerating into plants, cutting and repairing to cause a loss-of-function mutation in the MsPALM1 gene of Medicago sativa cells, and then screening the mutant plants by restriction endonuclease digestion and/or targeted deep sequencing of the target sites of the regenerated plants to obtain lines carrying four MsPALM1 allelic genes with simultaneous loss of function mutation. After phenotypic identification, it was confirmed that the compound leaves of the regenerated plants changed from three leaflets to five leaflets. The method can quickly obtain multileaflet Medicago sativa materials with a short breeding period and stable trait.
1. A method of obtaining multileaflet Medicago sativa materials comprising loss-of-function MsPALM1 alleles, the method comprising:
Step (1), Introducing into a Medicago sativa cell an sgRNA which targets a sequence in the MsPALM1 gene and an expression cassette encoding a Cas9 protein wherein the sgRNA comprises the sequence set forth in SEQ ID NO:4;
Step (2), Cutting the target site in the MsPALM1 gene;
Step (3), Regenerating plants from the Medicago sativa cells in step 2
Step (4), Screening the regenerated plants for the presence of loss-of-function MsPALM1 alleles;
Step (5), Selecting the regenerated plants carrying four loss-of-function alleles for phenotypic identification, observing the compound leaf phenotype of the regenerated plants, and selecting plants with more than 3 leaflets in all the compound leaves as the generated multileaflet Medicago sativa materials.
2. The method of claim 1 , wherein the sgRNA is introduced via an expression cassette comprising the MtU6 promoter.
3. The method of claim 1 , wherein expression cassette encoding the Cas9 protein is operably linked to a CaMV 35S promoter and a tNOS terminator.
4. The method of claim 1 , wherein screening of step 4 comprises PCR amplification of the MsPALM1 gene region corresponding to the target site and restriction endonuclease digestion of the PCR products.
5. The method of claim 1 , wherein screening of step 4 comprises deep sequencing of the MsPALM1 gene region corresponding to the target site.
6. The method of claim 1 , further comprising using the multileaflet Medicago sativa plant produced by the method in conventional plant breeding methods.